
In a multi-center UK study, microRNA signatures matched NT-proBNP in identifying pulmonary hypertension (PH) but surpassed it in distinguishing PH subtypes. When combined with NT-proBNP, age, and sex, these biomarkers improved diagnostic accuracy and could guide personalized treatment strategies.
Like
Save
Share